Savara (SVRA) Stock Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free SVRA Stock Alerts $4.45 +0.21 (+4.95%) (As of 04/25/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Savara Stock Price Performance5 Day Performance-7.48%1 Month Performance-7.68%3 Month Performance-10.64%6 Month Performance+36.09%Year-To-Date Performance-5.32%1 Year Performance+148.60% Receive SVRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Savara and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> SVRA Stock Chart for Thursday, April, 25, 2024 SVRA Chart by TradingView Savara Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$4.69$4.24-9.59%$4.70$4.241.00 million shs$585.76 million04/23/2024$4.70$4.69-0.21%$4.78$4.63479,493 shs$647.92 million04/22/2024$4.81$4.70-2.29%$5.01$4.69684,874 shs$649.31 million04/19/2024$4.79$4.81+0.42%$4.83$4.63875,821 shs$664.50 million04/18/2024$4.96$4.79-3.43%$5.00$4.791.20 million shs$661.74 million04/17/2024$5.16$4.96-3.88%$5.20$4.922.06 million shs$685.22 million Get the Latest News and Ratings for SVRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Savara and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$5.04$5.16+2.38%$5.30$4.912.14 million shs$712.85 million04/15/2024$5.07$5.04-0.59%$5.15$4.891.86 million shs$696.28 million04/12/2024$5.34$5.07-5.06%$5.33$5.001.17 million shs$700.42 million04/11/2024$4.74$5.34+12.66%$5.34$4.771.67 million shs$737.71 million04/10/2024$4.90$4.74-3.27%$4.81$4.68543,956 shs$654.83 million04/09/2024$4.68$4.90+4.70%$4.93$4.64380,559 shs$676.94 million04/08/2024$4.78$4.68-2.09%$4.79$4.67355,139 shs$646.54 million04/05/2024$4.61$4.78+3.69%$4.82$4.55375,998 shs$660.36 million04/04/2024$4.79$4.61-3.76%$4.85$4.59378,041 shs$636.87 million04/03/2024$4.67$4.79+2.57%$4.82$4.60371,286 shs$661.74 million04/02/2024$4.84$4.67-3.51%$4.80$4.62383,618 shs$645.16 million04/01/2024$4.98$4.84-2.81%$5.00$4.80632,419 shs$668.64 million03/29/2024$4.98$4.98$5.00$4.85904,349 shs$687.99 million03/28/2024$4.85$4.98+2.68%$4.99$4.85904,245 shs$687.99 million03/27/2024$4.91$4.85-1.22%$4.96$4.83356,279 shs$670.03 million03/26/2024$4.82$4.91+1.87%$4.93$4.83647,209 shs$678.31 million03/25/2024$4.80$4.82+0.42%$4.91$4.76447,163 shs$665.88 million03/22/2024$4.89$4.80-1.84%$4.91$4.79557,116 shs$663.12 million03/21/2024$4.89$4.89$4.99$4.88365,309 shs$675.55 million03/20/2024$4.86$4.89+0.62%$4.92$4.73454,134 shs$675.55 million03/19/2024$4.71$4.86+3.18%$4.89$4.64520,234 shs$671.41 million03/18/2024$4.71$4.71$4.74$4.52614,915 shs$650.69 million03/15/2024$4.66$4.71+1.07%$4.79$4.61834,597 shs$650.69 million03/14/2024$4.89$4.66-4.70%$4.89$4.62586,507 shs$643.78 million03/13/2024$4.92$4.89-0.61%$5.00$4.88461,298 shs$675.55 million03/12/2024$4.91$4.92+0.20%$4.96$4.78609,430 shs$679.70 million03/11/2024$5.30$4.91-7.36%$5.30$4.90897,105 shs$678.32 million03/08/2024$5.59$5.30-5.19%$5.59$5.131.21 million shs$717.30 million03/07/2024$5.42$5.59+3.14%$5.61$5.35749,797 shs$733.54 million03/06/2024$5.43$5.42-0.18%$5.47$5.33510,458 shs$733.54 million03/05/2024$5.51$5.43-1.45%$5.70$5.43980,271 shs$734.90 million03/04/2024$5.16$5.51+6.78%$5.57$5.261.49 million shs$745.72 million03/01/2024$5.05$5.16+2.18%$5.25$5.071.14 million shs$698.35 million02/29/2024$5.09$5.05-0.79%$5.20$5.011.93 million shs$683.47 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>02/28/2024$5.30$5.09-3.96%$5.31$5.03734,725 shs$688.88 million02/27/2024$5.22$5.30+1.53%$5.40$5.16583,320 shs$717.30 million02/26/2024$5.12$5.22+1.95%$5.44$5.07946,065 shs$706.48 million02/23/2024$4.91$5.12+4.28%$5.13$4.89954,251 shs$692.94 million02/22/2024$4.80$4.91+2.29%$4.99$4.80747,142 shs$664.52 million02/21/2024$4.82$4.80-0.41%$4.82$4.70595,970 shs$649.63 million02/20/2024$4.97$4.82-3.02%$4.99$4.73803,541 shs$652.34 million02/19/2024$4.97$4.97$5.00$4.91821,000 shs$672.64 million02/16/2024$4.97$4.97$5.00$4.91821,040 shs$672.64 million02/15/2024$5.00$4.97-0.60%$5.05$4.901.90 million shs$672.64 million02/14/2024$4.78$5.00+4.60%$5.04$4.791.90 million shs$676.70 million02/13/2024$5.00$4.78-4.40%$4.97$4.72995,336 shs$646.93 million02/12/2024$4.88$5.00+2.46%$5.09$4.861.07 million shs$676.70 million02/09/2024$4.77$4.88+2.31%$4.95$4.79726,831 shs$660.46 million02/08/2024$4.73$4.77+0.85%$4.81$4.68720,778 shs$645.57 million02/07/2024$4.80$4.73-1.46%$4.83$4.69715,413 shs$640.16 million02/06/2024$4.71$4.80+1.91%$4.80$4.63349,728 shs$649.63 million02/05/2024$4.85$4.71-2.89%$4.80$4.57583,731 shs$637.45 million02/02/2024$5.06$4.85-4.15%$5.10$4.84543,330 shs$656.40 million02/01/2024$4.94$5.06+2.43%$5.14$4.901.09 million shs$684.82 million01/31/2024$5.05$4.94-2.18%$5.16$4.93558,526 shs$668.58 million01/30/2024$4.99$5.05+1.20%$5.29$5.01760,346 shs$683.47 million01/29/2024$4.80$4.99+3.96%$4.99$4.72876,154 shs$675.35 million01/26/2024$4.98$4.80-3.61%$5.01$4.79478,252 shs$649.63 million01/25/2024$4.94$4.98+0.81%$5.14$4.96818,249 shs$673.99 million01/24/2024$5.05$4.94-2.18%$5.28$4.911.44 million shs$668.58 million Related Companies: AVTE Stock Price Chart PRAX Stock Price Chart PHAR Stock Price Chart IRON Stock Price Chart COGT Stock Price Chart YMAB Stock Price Chart SIGA Stock Price Chart SLN Stock Price Chart WVE Stock Price Chart LYEL Stock Price Chart Receive SVRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Savara and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SVRA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Savara Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.